ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,051.09
0.00%
US Tech 100
21,191.20
0.62%
Dow Jones
43,828.06
-0.20%
Brent Oil
74.135
0.00%
Bitcoin
101,553.88
0.10%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Aclarion Inc (ACONW)

  7. Aclarion Inc (ACONW) News

ACONW

Aclarion (ACONW)

Aclarion Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACONW
DateTimeSourceHeadlineSymbolCompany
12/02/20246:01AMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ACONWAclarion Inc
11/27/20244:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONWAclarion Inc
11/22/20244:03PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ACONWAclarion Inc
11/21/20248:00AMGlobeNewswire Inc.Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM FlashNASDAQ:ACONWAclarion Inc
11/14/20241:03PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ACONWAclarion Inc
11/13/20243:06PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:ACONWAclarion Inc
11/08/20244:18PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ACONWAclarion Inc
11/05/20246:00AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ACONWAclarion Inc
11/05/20246:00AMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ACONWAclarion Inc
11/05/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ACONWAclarion Inc
11/04/20246:15AMEdgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ACONWAclarion Inc
10/25/20245:05PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ACONWAclarion Inc
10/25/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ACONWAclarion Inc
10/15/20244:00PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ACONWAclarion Inc
10/11/20244:36PMEdgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ACONWAclarion Inc
10/11/20244:20PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONWAclarion Inc
10/10/20247:00AMGlobeNewswire Inc.Aclarion to Participate in the 2024 Maxim Healthcare Virtual SummitNASDAQ:ACONWAclarion Inc
10/01/20244:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONWAclarion Inc
09/27/20246:57AMGlobeNewswire Inc.Aclarion's Nociscan AI Plays Key Role in Advanced Understanding of Modic ChangesNASDAQ:ACONWAclarion Inc
09/24/20244:58PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONWAclarion Inc
09/24/20244:54PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ACONWAclarion Inc
09/24/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ACONWAclarion Inc
09/23/20244:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ACONWAclarion Inc
09/19/20245:02PMEdgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:ACONWAclarion Inc
09/12/20246:57AMGlobeNewswire Inc.Aclarion Provides Corporate Update on Nociscan AI Technology MilestonesNASDAQ:ACONWAclarion Inc
09/10/20246:57AMGlobeNewswire Inc.Aclarion Announces Completion of First Nociscan Exams in LIFEHAB TrialNASDAQ:ACONWAclarion Inc
09/05/20246:57AMGlobeNewswire Inc.Aclarion Launches Surgeon Partnership to Apply Nociscan’s AI Technology to Personal Injury and Workers Compensation MarketNASDAQ:ACONWAclarion Inc
08/29/20246:57AMGlobeNewswire Inc.Aclarion Launches Second Clinical Utility and Economic (CLUE) Trial Site With First Surgeon in New JerseyNASDAQ:ACONWAclarion Inc
08/21/20247:57AMGlobeNewswire Inc.Aclarion Launches the Clinical Utility and Economic (CLUE) Trial to Quantify How Often Nociscan’s AI Generated Biomarker Data Changes Surgical Treatment PlansNASDAQ:ACONWAclarion Inc
08/15/20249:48AMGlobeNewswire Inc.Aclarion to Present at August 20th Virtual Investor Summit Microcap EventNASDAQ:ACONWAclarion Inc
 Showing the most relevant articles for your search:NASDAQ:ACONW

Your Recent History

USOTC
WNFT
Worldwide NFT (PK)
NASDAQ
TNXP
Tonix Pharmaceuticals
USOTC
TGLO
TheGlobe com (PK)
USOTC
ICTY
Eyecity Com (PK)
USOTC
GTCH
GBT Technologies (PK)
USOTC
NSAV
Net Savings Link (PK)
USOTC
CGAC
Code Green Apparel (PK)
USOTC
CEOS
CeCors (PK)
USOTC
HIRU
Hiru (PK)
USOTC
LQMT
Liquidmetal Technologies (QB)
USOTC
NLST
Netlist (QB)
NASDAQ
AMRN
Amarin
COIN
BTCUSD
Bitcoin
USOTC
ELTP
Elite Pharmaceuticals (QB)
NASDAQ
NB
NioCorp Developments
NASDAQ
FCEL
FuelCell Energy
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved